Stay updated with breaking news from Dimensions Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wealth Dimensions Group Ltd. reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% during the 1st quarter, HoldingsChannel.com reports. The fund owned 4,221 shares of the healthcare product maker’s stock after selling 146 shares during the quarter. Wealth Dimensions Group Ltd.’s holdings in Abbott Laboratories were worth $427,000 at the end of […]
Wealth Dimensions Group Ltd. boosted its position in Starbucks Co. (NASDAQ:SBUX – Free Report) by 20.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,400 shares of the coffee company’s stock after purchasing an additional 582 shares during the period. Wealth Dimensions Group […]
Wealth Dimensions Group Ltd. lifted its stake in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 8.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,007 shares of the company’s stock after purchasing an additional 649 shares […]
Wealth Dimensions Group Ltd. increased its position in Invesco QQQ (NASDAQ:QQQ – Free Report) by 45.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,605 shares of the exchange traded fund’s stock after acquiring an additional 500 shares during […]
Wealth Dimensions Group Ltd. raised its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 13.9% in the first quarter, Holdings Channel.com reports. The firm owned 3,752 shares of the medical research company’s stock after buying an additional 459 shares during the period. Wealth Dimensions Group Ltd.’s holdings in Amgen were worth $907,000 […]